Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
NCT Number: NCT00869479
The Primary Aim of this study is to validate a questionnaire as a screening tool to identify subjects with symptoms suggestive of nephrogenic systemic fibrosis (NSF). The investigators believe that there will be difference between subjects with NSF and other skin conditions and normal skin.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Boston, Massachusetts, 02114, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day
Time frame: 1 day
Time frame: 1 day
Massachusetts General Hospital
Other
Validation of a Questionnaire as a Screening Tool to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00677092
Chronic Disease, Disease Attributes
Boston, Massachusetts, United States
View Trial DetailsNCT01014754
Fibrosis, Nephrogenic Fibrosing Dermopathy
Chicago, Illinois, United States
View Trial DetailsNCT01135316
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New York, United States
View Trial DetailsNCT00981942
Fibrosis, Nephrogenic Fibrosing Dermopathy
Aarhus, Denmark
View Trial Details